Target intelligence / Profile preview

Long intergenic non-protein coding RNA 682 (LINC00682)

Target
LINC00682
Molecular classification
Long non-coding RNA, Other
01

Overview

Long intergenic non-protein coding RNA 682 (LINC00682) is a long non-coding RNA (lncRNA), defined as a transcript longer than 200 nucleotides that does not encode a protein[1][5][7]. It is classified as an intergenic lncRNA and is located on chromosome 4 (41,872,738-41,882,955, reverse strand)[5][7]. LINC00682 functions mainly as a tumor suppressor in gastric cancer; it inhibits the progression of gastric cancer by regulating the microRNA-9 (miR-9) and LIM homeobox transcription factor 1 alpha (LMX1A) signaling axis, leading to decreased cell proliferation, migration, and invasion[2][3][4][9]. LINC00682 acts as a molecular sponge for miR-9, thereby reducing miR-9's inhibition of LMX1A, which is a known tumor suppressor[2][3][9]. Increased LINC00682 expression is associated with reduced gastric cancer cell aggressiveness and may serve as a potential biomarker for gastric cancer diagnosis or prognosis[3][9]. There are currently no known drugs that directly target LINC00682, and its role is primarily as a regulatory RNA rather than a therapeutic target in the conventional sense of druggable proteins or receptors[3][9].

Other names
LINC00682
02

Biological functions

Regulation of cell proliferationRegulation of apoptosisTumor suppressionRegulation of cell migration and invasion
03

Disease associations

CancerGastric cancerOther
04

Biomarkers

Potential diagnostic or prognostic biomarker for gastric cancer

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 682 (LINC00682).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 682 (LINC00682).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call